Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance
Clinical trial NCT02673749 · COMPLETED
Trial details
- NCT number
- NCT02673749
- Sponsor
- Ritter Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-10-01
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.